Dr. Minerva Martinez Cruz, PSICOLOGA Psychologist Medicare: Not Enrolled in Medicare Practice Location: Centro Psicologico Y Educativo, Ave Gilberto Concepcion De Gracia #7 3 Ste 2, Sierra Bayamon, PR 00961 Phone: 787-778-3113 Fax: 787-778-3113 |
News Archive
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
Catherine Zeta Jones – the 41-year-old Welsh actor checked into a day clinic in Connecticut for five days earlier this month for the treatment of bipolar disorder. "After dealing with the stress of the past year, Catherine made the decision to check in to a mental health facility for a brief stay to treat her Bipolar II Disorder," said publicist Cece Yorke said in a statement adding, "She's feeling great and looking forward to starting work this week on her two upcoming films."
A new policy report released today by the global non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) highlights how the development of therapeutics has been relatively neglected in the global response to COVID-19 and warns that with the few treatment innovations available principally in high-income countries, we risk repeating history and replicating the vaccine inequality that has become a defining characteristic of this global pandemic.
Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery.
Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) today reported that they have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells.
› Verified 7 days ago